CLINICAL_TRIALS
trial_result
· 2025-02-21
Clinical Trial Update: FIRAZYR General Drug Use-Results Survey (Japan)
Summary
A completed Japan-based survey evaluating real-world use of Firazyr (icatibant) for hereditary angioedema, with results posted in 2025.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Hereditary Angioedema (HAE) | Status: COMPLETED | Results posted: 2025-02-21